Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 1, 2009, Pages 95-102

  Zheng, Jie ^a   Cui, Shenghui ^a,b   Meng, Jianghong ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b Food and Drug Administration   (China)

Author keywords

Antimicrobial resistance; Multidrug resistance; Regulation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; DANOFLOXACIN; DIFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ENROFLOXACIN; GATIFLOXACIN; GENE PRODUCT; LEVOFLOXACIN; NALIDIXIC ACID; NORDIFLOXACIN; ORBIFLOXACIN; PROTEIN ACRAB; PROTEIN ACREF; PROTEIN PARC; PROTEIN PARE; SULFAMETHOXAZOLE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RAMA; TRANSCRIPTION FACTOR SOXS; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; GENE DELETION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POINT MUTATION; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS; UPREGULATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CARRIER PROTEINS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GENE DELETION; GENETIC COMPLEMENTATION TEST; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, MESSENGER; SALMONELLA TYPHIMURIUM; TRANS-ACTIVATORS;

EID: 57649180455     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn448     Document Type: Article

References (52)

1. Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607-25.
2. Izumiya H, Mori K, Kurazono T et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan. J Clin Microbiol 2005; 43 5074-9.
3. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. Paratyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101: 308-10.
4. Hakanen A, Siitonen A, Kotilainen P et al. Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997. J Antimicrob Chemother 1999; 43: 145-8.
5. Olsen SJ, DeBess EE, McGivern TE et al. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N Engl J Med 2001; 344: 1572-9.
6. Varma JK, Greene KD, Ovitt J et al. Hospitalization and antimicrobial resistance in Salmonella outbreaks, 1984-2002. Emerg Infect Dis 2005; 11: 943-6.
7. Chiu CH, Wu TL, Su LH et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 2002; 346: 413-9.
8. Carattoli A. Importance of integrons in the diffusion of resistance. Vet Res 2001; 32: 243-59.
9. Carattoli A. Plasmid-mediated antimicrobial resistance in Salmonella enterica. Curr Issues Mol Biol 2003; 5: 113-22.
10. Doublet B, Schwarz S, Kehrenberg C et al. Florfenicol resistance gene floR is part of a novel transposon. Antimicrob Agents Chemother 2005; 49: 2106-8.
11. Levesque C, Piche L, Larose C et al. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-91.
12. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004; 64: 159-204.
13. Poole K. Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol 2001; 4: 500-8.
14. Ariza RR, Li Z, Ringstad N et al. Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J Bacteriol 1995; 177: 1655-61.
15. Amabile-Cuevas CF, Demple B. Molecular characterization of the soxRS genes of Escherichia coli: Two genes control a superoxide stress regulon. Nucleic Acids Res 1991; 19: 4479-84.
16. Hachler H, Cohen SP, Levy SB. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. J Bacteriol 1991; 173: 5532-8.
17. Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: The mar regulon. Antimicrob Agents Chemother 1997; 41: 2067-75.
18. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 2000; 182: 3467-74.
19. Bennik MH, Pomposiello PJ, Thorne DF et al. Defining a rob regulon in Escherichia coli by using transposon mutagenesis. J Bacteriol 2000; 182: 3794-801.
20. White DG, Goldman JD, Demple B et al. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol 1997; 179: 6122-6.
21. Okusu H, Ma D, Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 1996; 178: 306-8.
22. Nunoshiba T, Hidalgo E, Amabile Cuevas CF et al. Two-stage control of an oxidative stress regulon: The Escherichia coli SoxR protein triggers redox-inducible expression of the soxS regulatory gene. J Bacteriol 1992; 174: 6054-60.
23. Ding H, Demple B. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator. Proc Natl Acad Sci USA 2000; 97: 5146-50.
24. Koutsolioutsou A, Pena-Llopis S, Demple B. Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia ooli isolates. Antimicrob Agents Chemother 2005; 49: 2746-52.
25. Koutsolioutsou A, Martins EA, White DG et al. A soxRS constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium). Antimicrob Agents Chemother 2001; 45: 38-43.
26. George AM, Hall RM, Stokes HW. Multidrug resistance in Klebsiella pneumoniae: A novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 1995; 141: 1909-20.
27. Chollet R, Chevalier J, Bollet C et al. RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48: 2518-23.
28. Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist 2007; 13: 1-6.
29. Yassien MA, Ewis HE, Lu CD et al. Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma gene, which confers multiple drug resistance in Escherichia coli. Antimicrob Agents Chemother 2002; 46: 360-6.
30. van der Straaten T, Janssen R, Mevius DJ et al. Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2004; 48: 2292-4.
31. Chen S, Cui S, McDermott PF et al. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar Typhimurium to fluoroquinolones and other antimicrobials. Antimicrob Agents Chemother 2007; 51: 535-42.
32. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
33. Donnenberg MS, Kaper JB. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 1991; 59: 4310-7.
34. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals - Second Edition: Approved Standard M31-A2. NCCLS, Wayne, PA, USA, 2002.
35. Bio-Rad L. Instruction Manual, iQ5 Optical System Software, Rev. B. Bulletin #10005604.
36. Eaves DJ, Ricci V, Piddock LJ. Expression of acrB, acrF, acrD, marA and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob Agents Chemother 2004; 48: 1145-50.
37. Chou JH, Greenberg JT, Demple B. Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: Positive control of the micF antisense RNA by the soxRS locus. J Bacteriol 1993; 175: 1026-31.
38. Hakanen A, Kotilainen P, Jalava J et al. Detection of decreased fluoroquinolone susceptibility in Salmonella and validation of nalidixic acid screening test. J Clin Microbiol 1999; 37: 3572-7.
39. Piddock LJ, Ricci V, McLaren I et al. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant Salmonella serotypes isolated from animals in the United Kingdom. J Antimicrob Chemother 1998; 41: 635-41.
40. Heisig P. High-level fluoroquinolone resistance in a Salmonella Typhimurium isolate due to alterations in both gyrA and gyrB genes. J Antimicrob Chemother 1993; 32: 367-77.
41. Piddock LJ. Fluoroquinolone resistance in Salmonella serovars isolated from humans and food animals. FEMS Microbiol Rev 2002; 26: 3-16.
42. Brown JC, Thomson CJ, Amyes SG. Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decreased susceptibilities to 4-quinolone drugs. J Antimicrob Chemother 1996; 37: 351-6.
43. Griggs DJ, Gensberg K, Piddlock LJ. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob Agents Chemother 1996; 40: 1009-13.
44. Baucheron S, Chaslus-Dancla E, Cloeckaert A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J Antimicrob Chemother 2004; 53: 657-9.
45. Ling JM, Chan EW, Lam AW et al. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother 2003; 47: 3567-73.
46. Hansen H, Heisig P. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro. Microb Drug Resist 2003; 9: 25-32.
47. Webber MA, Piddock U. Absence of mutations in marRAB or soxRS in acrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob Agents Chemother 2001; 45: 1550-2.
48. Grkovic S, Brown MH, Skurray RA. Transcriptional regulation of multidrug efflux pumps in bacteria. Semin Cell Dev Biol 2001; 12: 225-37.
49. Oethinger M, Podglajen I, Kern WV et al. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother 1998; 42: 2089-94.
50. Ruzin A, Visalli MA, Keeney D et al. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 2005; 49: 1017-22.
51. Abouzeed YM, Baucheron S, Cloeckaert A. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008; 52: 2428-34.
52. Nikaido E, Yamaguchi A, Nishino K. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 2008; 283: 24245-53.